{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:35:39Z","timestamp":1740173739518,"version":"3.37.3"},"reference-count":17,"publisher":"Conselho Federal de Farmacia","issue":"3","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infarma"],"abstract":"<jats:p>Se avaliar procedimentos \u00e9 importante em todas as \u00e1reas, na sa\u00fade a sua relev\u00e2ncia tem um papel acrescido.\u00a0Essa preocupa\u00e7\u00e3o na cria\u00e7\u00e3o de sistemas que permitam avaliar o circuito e gest\u00e3o dos medicamentos em\u00a0espa\u00e7os onde residem idosos, assume uma import\u00e2ncia que tem de ser devidamente enquadrada. \u00c9 not\u00f3rio\u00a0que muitos Problemas Relacionados com os Medicamentos (PRM) podem ser facilmente identificados\u00a0quando existem sistemas integrados de controlo eficientes, diminuindo o risco de exposi\u00e7\u00e3o a erros de medicamentos.\u00a0Ao longo desta nota t\u00e9cnica, procuramos analisar alguns trabalhos publicados nos \u00faltimos anos,\u00a0nest \u00e1rea. Diferentes estudos com diferentes protocolos, avaliaram m\u00faltiplas vari\u00e1veis no circuito e gest\u00e3o\u00a0do medicamento em Institui\u00e7\u00f5es de Longa Perman\u00eancia para Idosos (ILPI). Assim, da an\u00e1lise desses estudos,\u00a0levantamos alguns pontos que podem e devem ser mais aprofundados no futuro, tendo o farmac\u00eautico\u00a0um papel ativo neste assunto.<\/jats:p>","DOI":"10.14450\/2318-9312.v31.e3.a2019.pp233-239","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T08:53:40Z","timestamp":1570784020000},"page":"233-239","source":"Crossref","is-referenced-by-count":0,"title":["A IMPORT\u00c2NCIA DA AVALIA\u00c7\u00c3O DO CIRCUITO E GEST\u00c3O DA MEDICA\u00c7\u00c3O NAS INSTITUI\u00c7\u00d5ES DE LONGA PERMAN\u00caNCIA PARA IDOSOS (ILPI): IDENTIFICA\u00c7\u00c3O DE PROBLEMAS RELACIONADO COM OS MEDICAMENTOS"],"prefix":"10.14450","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-6021","authenticated-orcid":false,"given":"Renato","family":"Ferreira da Silva","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-4021","authenticated-orcid":false,"given":"Carina","family":"Vieira","sequence":"additional","affiliation":[]}],"member":"5578","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"ref0","unstructured":"1. PORTUGAL. Instituto Portugu\u00eas da Qualidade. Recomenda\u00e7\u00e3o da Comiss\u00e3o Setorial para a Sa\u00fade do Sistema Portugu\u00eas da Qualidade - CS\/09, de 11 de dezembro de 2014. Gest\u00e3o da Medica\u00e7\u00e3o nas Estruturas Residenciais para Pessoas Idosas (ERPI). Qualidade CSpaSdSPd, editor. 2014."},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Costa FA, Silvestre L, Periquito C, Carneiro C, Oliveira P, Fernandes AI, et al. Drug-Related Problems Identified in a Sample of Portuguese Institutionalised Elderly Patients and Pharmacists' Interventions to Improve Safety and Effectiveness of Medicines. Drugs Real World Outcomes. 2016;3(1):89-97. DOI: 10.1007\/s40801-016-0061-x.","DOI":"10.1007\/s40801-016-0061-x"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Silva C, Ramalho C, Luz I, Monteiro J, Fresco P. Drugrelated problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention. Int J Clin Pharm. 2015;37(2):327-334. DOI: 10.1007\/s11096-014-0063-2.","DOI":"10.1007\/s11096-014-0063-2"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. DOI: 10.1186\/s12877-017-0621-2.","DOI":"10.1186\/s12877-017-0621-2"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Turnheim K. Drug therapy in the elderly. Exp Gerontol. 2004;39(11-12):1731-8. DOI: 10.1016\/j.exger.2004.05.011.","DOI":"10.1016\/j.exger.2004.05.011"},{"key":"ref5","unstructured":"6. Campos AC. Health Reforms - the conductor wire. Edi\u00e7\u00f5es Almedina. 2008."},{"key":"ref6","unstructured":"7. Guerreiro MP, Cnatrill JM, Pisco L, Martins AP, Considerations on preventable drug related morbidity in primary care part I - impact of preventable drug-related morbidity. Rev Port Clin Geral. 2005:21:269-279."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Hazen ACM, Zwart DLM, Poldervaart JM, de Gier JJ, de Wit NJ, de Bont AA, Bouvy ML. Non-dispensing pharmacists' actions and solutions of drug therapy problems among elderly polypharmacy patients in primary care. Fam Pract. 2019. DOI: 10.1093\/fampra\/cmy114.","DOI":"10.1093\/fampra\/cmy114"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2 [published correction appears in Age Ageing. 2018 May 1;47(3):489]. Age Ageing. 2015;44(2):213-218. DOI: 10.1093\/ageing\/afu145.","DOI":"10.1093\/ageing\/afu145"},{"key":"ref9","unstructured":"10. Periquito CM, Silva PC, Oliveira P, Carneiro C, Fernandes AI, Costa FA. Revis\u00e3o da medica\u00e7\u00e3o em idosos institucionalizados: aplica\u00e7\u00e3o dos crit\u00e9rios STOPP e START. Rev Port Farmacoter. 2014;6:211-217. DOI: 10\/25756\/rpf.v6i4.20."},{"key":"ref10","unstructured":"11. Committee Consensus. Segundo Consenso de Granada sobre Problemas Relacionados con Medicamentos. Ars Pharm. 2002;43(3-4):175-184."},{"key":"ref11","unstructured":"12. Santos H, Iglesias P, Fernandez-Llimos F, Faus MJ, Rodrigues LM. Segundo Consenso de Granada sobre Problemas Relacionados com Medicamentos. Traduc\u00e3o intercultural de Espanhol para Portugu\u00eas (europeu). Acta Med Port. 2004; 17:59-66."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Modig S, Holmdahl L, Bondesson A. Medication reviews in primary care in Sweden: importance of clinical pharmacists' recommendations on drug-related problems. Int J Clin Pharm. 2016;38(1):41-45. DOI: 10.1007\/s11096-015-0189-x.","DOI":"10.1007\/s11096-015-0189-x"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Erzkamp S, Rose O. Development and evaluation of na algorithm-based tool for Medication Management in nursing homes: the AMBER study protocol. BMJ Open 2018;8: e019398. DOI: 10.1136\/ bmjopen-2017-019398.","DOI":"10.1136\/bmjopen-2017-019398"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Meyboom, Ronald HB, Marie Lindquist, and Antoine CG Egberts. An ABC of drug-related problems. Drug Safety. 2000;22(6):415-423. DOI: 10.2165\/00002018-200022060-00001.","DOI":"10.2165\/00002018-200022060-00001"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38(5):859-867. DOI: 10.1345\/aph.1D182.","DOI":"10.1345\/aph.1D182"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Odberg KR, Hansen BS, Aase K, Wangensteen S. Medication administration and interruptions in nursing homes: A qualitative observational study. J Clin Nursing. 2018;27(5-6):1113-1124. DOI: 10.1111\/jocn.14138.","DOI":"10.1111\/jocn.14138"}],"container-title":["Infarma - Ci\u00eancias Farmac\u00eauticas"],"original-title":[],"language":"pt","link":[{"URL":"http:\/\/www.revistas.cff.org.br\/?journal=infarma&page=article&op=viewFile&path[]=2508&path[]=pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.revistas.cff.org.br\/?journal=infarma&page=article&op=viewFile&path[]=2508&path[]=pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T10:52:28Z","timestamp":1606819948000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.revistas.cff.org.br\/?journal=infarma&page=article&op=view&path[]=2508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,10,7]]}},"URL":"https:\/\/doi.org\/10.14450\/2318-9312.v31.e3.a2019.pp233-239","archive":["CLOCKSS","CLOCKSS"],"relation":{},"ISSN":["2318-9312","0104-0219"],"issn-type":[{"type":"electronic","value":"2318-9312"},{"type":"print","value":"0104-0219"}],"subject":[],"published":{"date-parts":[[2019,10,7]]}}}